Journal Guide

Oncology and hematology professionals are continuously charged with staying on the cutting–edge of new medical treatments and technologies to foster better cancer patient care and practice management. To that end, The Oncologist® is dedicated to translating the latest research developments into best multimodality practice.Established by oncologists for oncologists, the Journal is committed to helping physicians excel in a challenging and ever-changing environment; to ensure their patients’ rights to the highest level of care from screening and prevention to diagnosis, treatment and management of the disease.Designed specifically for the busy practitioner, The Oncologist is devoted to medical and practice issues for surgical, radiation, and medical oncologists. With emphasis on clear, concise interpretation, rather than data, the Journal's articles are meant to impact the practice of oncology and to facilitate significant communication in the introduction and application of new advancements.The Oncologist'sSenior Editors believe that the various oncology subspecialists should share the same information base and read the same journal. It is up to us, as leaders in this field, to defend the patient's needs and rights and to assure that the patient has an advocate. In order to do so, we have to be united and fully informed. We pledge to put the best and latest information on cancer management before our readership, to help prepare them for the future, and to do their best as a team to improve outcomes and quality of life for every patient.Manuscripts are reviewed by two or more field experts and, when accepted, are published expeditiously—generally within 12 weeks. When a contribution is of such relevance as to significantly impact public health, authors may request Fast Track Review for a Rapid Communication, in which case an editorial decision will be made within 2 weeks of submission.The Oncologist challenges its readers to understand what is new and better, to glimpse the future, not only in terms of research, but also in terms of new team approaches to disease management. In short, we want our readers to explore how cancer medicine could be and will be practiced now and throughout the 21st century.CORRESPONDENCEEditorial correspondence, including submissions for publication or letters to the Editor, should be addressed to the Executive Editor. Submissions for publication in the Fundamentals in Cancer Medicine section should also be addressed to the Executive Editor.Information for Authors can be found at the back of each issue, or contact the AlphaMed Press Editorial Office.Advertising: Correspondence and rate requests should be addressed to the Publisher.Change of Address notices: Both the subscriber's old and new address should be e-mailed to AlphaMed Press at least one month in advance. You can also mail the information to: AlphaMed Press, c/o Cambey & West, PO Box 412, Congers, New York 10920-9914 USA.

The Pharmacogenomics Journal is a print and electronic journal, which is dedicated to the rapid publication of original research on pharmacogenomics and its clinical applications.Key areas of coverage include: * Personalized medicine * Effects of genetic variability on drug toxicity and efficacy * Identification and functional characterization of polymorphisms relevant to drug action * Pharmacodynamic and pharmacokinetic variations and drug efficacy * Integration of new developments in the genome project and proteomics into clinical medicine, pharmacology, and therapeutics * Clinical applications of genomic science * Identification of novel genomic targets for drug development * Potential benefits of pharmacogenomics.

The Plant Cell publishes novel research of special significance in plant biology, especially in the areas of cellular biology, molecular biology, genetics, development, and evolution. The primary criteria for publication are that the article provides new insight that is of broad interest to plant biologists, not only to specialists, and that the presentation of results is appropriate for a wide audience of plant biologists.The Plant Cell was founded on four key tenets: (1) to publish the most exciting, cutting-edge research in plant cellular and molecular biology, (2) to provide the most rapid turnaround time possible for reviewing and publishing a research paper, (3) to feature the highest quality reproduction of data, and (4) to provide, in the front section of the journal, a more interactive format for commentaries, opinion pieces, and the exchange of information and ideas in review articles, meeting reports, and insightful overviews of featured research papers.For information about library subscriptions, contact Suzanne Cholwek at ASPB Library Subscription Services. For information about the prices for individual subscriptions, which are available to members of the American Society of Plant Biologists, contact ASPB Member Services. You may also update your mailing address for subscriptions or membership contact information.

Publishing the best original research papers in all key areas of modern plant biology from the world's leading laboratories, The Plant Journal provides a dynamic forum for this ever growing international research community. Plant science research is now at the forefront of research in the biological sciences, with breakthroughs in our understanding of fundamental processes in plants matching those in other organisms. The impact of molecular genetics and the availability of model and crop species can be seen in all aspects of plant biology. For publication in The Plant Journal the research must provide a highly significant new contribution to our understanding of plants and be of general interest to the plant science community. All areas of plant biology are welcome and the experimental approaches used can be wide-ranging. While The Plant Journal recognizes the importance of biotechnology for plant improvement, it does not publish full research papers that do not provide fundamental advances in plant biology. Authors:.

This Journal publishes original research work on all aspects of protein investigations, including studies concerned with covalent or three-dimensional structure, assembly, genetics, evolution, proteomics, molecular biology, engineering, and peptide synthesis. The contents include the application of research to the elucidation and interpretation of the molecular bases of the biological activity of proteins.The Protein Journal iThenticate to scan all submitted manuscripts. iThenticate is a plagiarism screening service that verifies the originality of content submitted before publication. iThenticate checks submissions against millions of published research papers, and billions of web content items. Authors, researchers and freelancers can also use iThenticate to screen their work before submission by visiting www.ithenticate.com.Details on the Submission and Publicationd procedures:
- No Page Charges
- No Fees for Online Color Images
- Optional Color Images in Print – Euro 950,-
- Optional Op

Theoretical and Applied Genetics publishes original research and review articles in all key areas of modern plant genetics, plant genomics and plant biotechnology. All work needs to have a clear genetic component and significant impact on plant breeding. Theoretical considerations are only accepted in combination with new experimental data and/or if they indicate a relevant application in plant genetics or breeding. Emphasizing the practical, the journal focuses on research into leading crop plants and articles presenting innovative approaches. Prospective review authors should contact the Reviews Editor before submitting a manuscript.

Thyroid, the Official Journal of the American Thyroid Association, is the leading resource for thyroidologists, endocrinologists, and internal medicine specialists to stay abreast of current reviews, commentaries, and clinical management strategies on all aspects of thyroid disease and treatment.The Journal is an indispensable resource for endocrinologists to stay up to date on the latest studies on thyroid diseases (thyroid dysfunction, workup of thyroid nodules, management of thyroid cancer), and other common disorders encountered in endocrine practice.Relevant for researchers in cell biology (autoimmunity, signaling, and hormone action), physiology, carcinogenesis, development, and genetics, Thyroid is also critical to a wide range of specialties including: internal medicine, endocrine surgery, pediatrics, OB/GYN, radiology, nuclear medicine, and pathology.Entering its 21st year, Thyroid remains unique in blending basic papers, clinical studies, and patient-focused reports, and is:* The repository for the best peer-reviewed translational research and clinical management in the field, offering online ahead-of-print publication* Covers all aspects of thyroid disease from primary care to clinical research* Global in scope, providing access to the most current research worldwide* The exclusive source for the Authoritative and Updated ATA Guidelines for Managing Thyroid Disease.

Thyroid Research is devoted to all aspects of thyroid hormones and thyroid diseases and their interaction with the cardiovascular, pulmonary, gastroenterological, metabolic and nervous systems.

Aims & Scope: Tissue Barriers is the first international cross-disciplinary journal that focuses on the architecture, biological roles and regulation of tissue barriers and intercellular junctions. We publish high quality peer-reviewed articles that cover a wide range of topics including structure and functions of the intestinal, airway, renal, epidermal and other types of tissue barriers, biology of  blood-brain and blood-testis barriers, molecular composition and dynamics of epithelial and endothelial junctions, leukocyte, tumor cell and pathogen interactions with epithelial and endothelial layers, non-cellular components of tissue barriers, barrier dysfunctions in diseases and drug delivery across epithelial and endothelial barriers.

Tissue Barriers publishes several categories of articles including: Original Research Papers, Short Communications, Technical Papers, Reviews, Perspectives and Commentaries, Hypothesis and Meeting Reports. Reviews and Perspectives/Commentaries will typically be invited. We also anticipate to publish special issues that are devoted to rapidly developing or controversial areas of research. Suggestions for topics are welcome.

Tissue Barriers has several goals:

• To promote cross-disciplinary awareness and collaborations between researchers working with different types of epithelial and endothelial barriers and build a broad and cohesive worldwide community of scientists interesting in this exciting field.
• To comprehend the enormous complexity of tissue barriers and map cross-talks and interactions between their different cellular and non-cellular components.
• To highlight the roles of tissue barrier dysfunctions in human diseases and accelerate a search for pharmacological enhancers of tissue barriers as potential therapeutic agents.
• To understand and optimize drug delivery across epithelial and endothelial barriers.

Publication office: Taylor & Francis, Group, 530 Walnut Street, Suite 850, Philadelphia, PA 19106. 

Tissue Engineering is the premier biomedical journal that brings together the principles of engineering and life sciences to generate new tissue development. It is a forum for groundbreaking scientific research and clinical application from the leading experts in the field. This multidisciplinary journal publishes cutting-edge, breakthrough research and applications on all aspects of tissue growth and regeneration.Anthony Atala, member of the Executive Editorial Board, when interviewed on a 60 Minutes segment, spoke about Regenerative Medicine and current developments in growing body parts. Dr. Atala is the director at Wake Forest Institute for Regenerative Medicine, which is currently growing various tissues for regenerating several body parts including bladders and kidneys, providing endless possibilities for the future of this field.During the interview, Dr. Atala explained “…the hope of the field is that some day we can provide replacement tissues and organs that can be used to help transplant patients who are waiting for organs to survive. Every organ in our body contains special stem cells that are unique to each body part. The key to regeneration is to isolate and then multiply those cells until there are enough to cover a mold of that particle body part.” The field of tissue engineering provides infinite possibilities in bioengineering and life science processes. .

issue Engineering is the premier biomedical journal that brings together the principles of engineering and life sciences to generate new tissue development. It is a forum for groundbreaking scientific research and clinical application from the leading experts in the field. This multidisciplinary journal publishes cutting-edge, breakthrough research and applications on all aspects of tissue growth and regeneration.Anthony Atala, member of the Executive Editorial Board, when interviewed on a 60 Minutes segment, spoke about Regenerative Medicine and current developments in growing body parts. Dr. Atala is the director at Wake Forest Institute for Regenerative Medicine, which is currently growing various tissues for regenerating several body parts including bladders and kidneys, providing endless possibilities for the future of this field.During the interview, Dr. Atala explained “…the hope of the field is that some day we can provide replacement tissues and organs that can be used to help transplant patients who are waiting for organs to survive. Every organ in our body contains special stem cells that are unique to each body part. The key to regeneration is to isolate and then multiply those cells until there are enough to cover a mold of that particle body part.” The field of tissue engineering provides infinite possibilities in .

Tissue & Cell is devoted to original research on the organization of cells, their components and extracellular products, at all levels including the grouping and interrelations of cells, in tissues and organs. Emphasis is placed on cell biological aspects of structure, function and behaviour of cells, and primarily morphological accounts must include substantially new information of general interest. Timely review articles on topics of particular interest, and accounts of new techniques and applications that deal with aspects of cell structure and function are invited.A new service for Authors - Submit your article onlineTo order this journal online, visit http://intl.elsevierhealth.com/journals/ticeBenefits to authorsWe also provide many author benefits, such as free PDFs, a liberal copyright policy, special discounts on Elsevier publications and much more. Please click here for more information on our author services.Please see our Guide for Authors for information on article submission. If you require any further information or help, please visit our support pages: http://support.elsevier.com

Toxicologic Pathology focuses on the multidisciplinary elements that constitute toxicologic pathology, including spontaneous and experimentally induced morphological and functional changes, environmental exposures, case reports, and risk assessment and investigative techniques. The journal publishes original articles, symposia papers, brief communications, current topic reviews, current issues, and fast-track articles.